Neurovascular unit dysfunction: A vascular component of Alzheimer disease?
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The structural and functional integrity of the CNS depends on the coupling between neural activity and cerebral blood flow (CBF) and the regulation of transport across the blood brain barrier (BBB). These two critical functions require the coordinated activity of a neurovascular unit that includes perivascular neurons, astrocytes, endothelial cells, and vascular smooth muscle cells. There is some experimental evidence that dysfunction of the neurovascular unit may be an early event in AD (AD).1 The functional organization of the neurovascular unit and its possible role in the pathogenesis of AD have been discussed in detail in several excellent reviews.1,2,3,4 Neurovascular mechanisms in AD may have important implications for the prevention of neuronal loss in this disorder. The coupling between neuronal activity and regional CBF is referred to as functional hyperemia.1,2 Functional hyperemia is triggered primarily by increases in synaptic activity, with a contribution of metabolic signals resulting from increased energy consumption by active neurons and astrocytes. This activity-related increase in CBF is due to the release of several vasodilator substances from perivascular neurons, astrocytes, and endothelial cells. These include extracellular potassium (K+) and hydrogen (H+) ions, adenosine, nitric oxide (NO), prostanoids, and neurotransmitters released from perivascular neuronal processes.1,2,3,5,6 Glutamate, which is released from active excitatory synapses, is not vasoactive but stimulates the release of NO, prostaglandins, and other vasodilator substances from target neurons and astrocytes (figure). Figure Some of the proposed mechanisms of functional hyperemia in response to excitatory synaptic activity Glutamate (Glu), released from excitatory synapses, activates NMDA (NMDA) receptors in neurons and metabotropic glutamate receptors (mGluR) in perisynaptic astrocytes. This results in increase in cytosolic levels of calcium (Ca2+), which triggers the production and release of several vasodilator substances from these cells. For example, Ca2+ stimulates phospholipase A2 …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Deane, R., Wu, Z., & Zlokovic, B. V. (2004) · Stroke · doi:10.1161/01.str.0000143452.85382.d1 · Cited by 392
Risk Factors for Vascular Dementia and Alzheimer Disease
Gorelick, P. B. (2004) · Stroke · doi:10.1161/01.str.0000143318.70292.47 · Cited by 365
Cited by
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601
The blood–spinal cord barrier: Morphology and Clinical Implications
Bartanusz, V., Jezova, D., Alajajian, B., & Digicaylioglu, M. (2011) · Annals of Neurology · doi:10.1002/ana.22421 · Cited by 481
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging
van de Haar, H. J., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Wong, S. M., Hofman, P. A. M., Burgmans, S., Verhey, F. R. J., & Backes, W. H. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.006 · Cited by 207
Metadata
- Venue
- Neurology
- Published
- 2007-05-15
- Volume
- 68
- Issue
- 20
- Pages
- 1730-1732
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2463822291
- Cited by
- 64
- References
- 5
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurovascular unit dysfunction: A vascular component of Alzheimer disease? https://app.cochat.ai/papers/10.1212/01.wnl.0000264502.92649.ab
- The paper
- Neurovascular unit dysfunction: A vascular component of Alzheimer disease? (2007). Neurology. https://doi.org/10.1212/01.wnl.0000264502.92649.ab
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.